Serum troponin, D‐dimer, and CRP level in severe coronavirus (COVID‐19) patients

Abstract

Background: Abnormal inflammation coagulation biomarker levels of troponin, C-reactive protein (CRP), and D-dimer levels in serum have been demonstrated to be associated and involved in the disease progression of coronavirus disease 2019 .Methods: First: the study aimed to investigate the correlation of troponin, CRP, D-dimer, white blood cell (WBC) and polymerase chain reaction-cycle threshold (PCR-Ct) within COVID-19 survivors (143 patients; 79 males, 64 females) and in deceased (30 patients; 12 males, 18 females) group. Also, assessing any differences between both groups in studied parameters. Second: a correlation study of studied parameters' level has been conducted within families (41 patients; 23 males [seven deaths] and 18 females [eight deaths]) that lost more than one member due to the severity of the disease. Also, differences between these family and control group (132 patients; 69 males and 63 females) group in studied parameters have been assessed. Results: In the first week of hospitalization, there were significant differences in D-dimer, CRP and troponin level between survived and deceased patient groups. In the second week of the admission, both groups had significant differences in the level of all studied parameters; troponin I, D-dimer, CRP, and WBCs. WBC levels positively correlated to CRP in male survivors (r = 0.75, p < 0.0001), and to troponin in deceased male patients (r = 0.74, p = 0.007). The second week of patient admission was critical in the group of families who lost more than one person, when troponin was correlated positively with D-dimer, CRP, and WBCs. Conclusion:Troponin, D-dimer, CRP, and WBCs level were significantly higher in COVID-19 patients who died than in COVID-19 survivors. High troponin and WBC levels, were considerably associated with families that lost more than one member, when compared with the unrelated COVID-19 patient control.

Disease severity and efficacy of homologous vaccination among patients infected with SARS‐CoV‐2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers

“…CRP test was conducted on an automated multiparametric analyzer Cobas C111 4 (Roche Diagnostics). 26 , 27 …”

“…CRP test was conducted on an automated multiparametric analyzer Cobas C111 4 (Roche Diagnostics). [26][27] Clinical classification of Severity Case Category of patients was…”

Clinical progress in MSC-based therapies for the management of severe COVID-19

“…The production of C-reactive protein (CRP) – synthesized by hepatocytes in response to infection or tissue inflammation – is stimulated by interleukin-6 (IL-6), interleukin-1 (IL-1) and TNF [14] . Therefore, the elevation of these cytokines in COVID-19 patients increase the CRP levels, making it one of the most effective and sensitive biomarkers to predict the disease severity and progression [15] , [16] . The presence of increased D-dimer has been also associated with poor prognosis in COVID-19 patients during hospitalization.…”

Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq

“…Laboratory findings in COVID-19 patients also may include lymphopenia and elevated levels of white blood cells (WBCs), erythrocyte sedimentation rate (ESR), d-dimer, C-reactive protein, and ferritin [ [15] , [16] , [17] , [18] , [19] ].…”